Yong-Ming Zhou1, Ming-Jiang Li2, Yan-Li Zhou2, Le-Le Ma2, Xin Yi2. 1. Department of Geriatrics, Renmin Hospital of Wuhan University Wuhan 430060, China. 2. Department of Cardiology, Renmin Hospital of Wuhan UniversityWuhan 430060, China; Cardiovascular Research Institute, Wuhan UniversityWuhan 430060, China.
Abstract
OBJECTIVE: Growth differentiation factor-15 (GDF-15) has been identified as a strong biomarker of cardiovascular diseases; however, no evidence are available concerning the relationship of GDF-15 and atrial fibrosis in patients with atrial fibrillation (AF) and rheumatic heart disease (RHD). METHODS: Twenty patients with rheumatic heart disease were divided into two groups, 10 cases with AF and 10 cases with sinus rhythm (SR). Clinical data and blood samples were collected; left atrial appendage was taken by the surgeon in the process of valve replacement. Masson stained sections and mRNA levels of cardiac fibrosis biomarkers were used to determine the level of cardiac fibrosis, the expression level of GDF-15 was evaluated via immunohistochemistry, enzyme-linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (PCR). RESULTS: Compared with SR group, more collagen deposited in the atrial tissue of AF group. The distribution of GDF-15 in the AF group was significantly higher than SR group (P<0.05). In addition, plasma GDF-15 level and mRNA level of GDF-15 in atrial tissue of AF showed the same trend as the result of immunohistochemistry. After linear correlation analysis, the expression level of GDF-15 was found to be positively related to the degree of cardiac fibrosis. CONCLUSION: GDF-15 might involve in the development and maintenance of atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease, and GDF-15 could be used as a novel biomarker to evaluate myocardial fibrosis in the future.
OBJECTIVE:Growth differentiation factor-15 (GDF-15) has been identified as a strong biomarker of cardiovascular diseases; however, no evidence are available concerning the relationship of GDF-15 and atrial fibrosis in patients with atrial fibrillation (AF) and rheumatic heart disease (RHD). METHODS: Twenty patients with rheumatic heart disease were divided into two groups, 10 cases with AF and 10 cases with sinus rhythm (SR). Clinical data and blood samples were collected; left atrial appendage was taken by the surgeon in the process of valve replacement. Masson stained sections and mRNA levels of cardiac fibrosis biomarkers were used to determine the level of cardiac fibrosis, the expression level of GDF-15 was evaluated via immunohistochemistry, enzyme-linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (PCR). RESULTS: Compared with SR group, more collagen deposited in the atrial tissue of AF group. The distribution of GDF-15 in the AF group was significantly higher than SR group (P<0.05). In addition, plasma GDF-15 level and mRNA level of GDF-15 in atrial tissue of AF showed the same trend as the result of immunohistochemistry. After linear correlation analysis, the expression level of GDF-15 was found to be positively related to the degree of cardiac fibrosis. CONCLUSION:GDF-15 might involve in the development and maintenance of atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease, and GDF-15 could be used as a novel biomarker to evaluate myocardial fibrosis in the future.
Authors: Samuel N Breit; Heiko Johnen; Andrew D Cook; Vicky W W Tsai; Mohammad G Mohammad; Tamara Kuffner; Hong Ping Zhang; Christopher P Marquis; Lele Jiang; Glen Lockwood; Michelle Lee-Ng; Yasmin Husaini; Liyun Wu; John A Hamilton; David A Brown Journal: Growth Factors Date: 2011-08-11 Impact factor: 2.511
Authors: Dirk J Lok; Ijsbrand T Klip; Sjoukje I Lok; Pieta W Bruggink-André de la Porte; Erik Badings; Jan van Wijngaarden; Adriaan A Voors; Rudolf A de Boer; Dirk J van Veldhuisen; Peter van der Meer Journal: Am J Cardiol Date: 2013-06-29 Impact factor: 2.778
Authors: Lie Ying Fan; Zhong Gan Jin; Ming Zong; Qing Zhong Wang; Yi Ju; Li Shan Sun; Yu Ying Gu; Ping Yu; Dai Fu Zhang; Zhong Min Liu Journal: Clin Lab Date: 2014 Impact factor: 1.138
Authors: Konstantinos P Letsas; Reinhold Weber; Gerd Bürkle; Constantinos C Mihas; Jan Minners; Dietrich Kalusche; Thomas Arentz Journal: Europace Date: 2008-11-13 Impact factor: 5.214
Authors: Hanna K Gaggin; Jackie Szymonifka; Anju Bhardwaj; Arianna Belcher; Benedetta De Berardinis; Shweta Motiwala; Thomas J Wang; James L Januzzi Journal: JACC Heart Fail Date: 2014-01-25 Impact factor: 12.035
Authors: Anita Saraf; Christine De Staercke; Ian Everitt; Alice Haouzi; Yi-An Ko; Staci Jennings; Jonathan H Kim; Fred H Rodriguez; Andreas P Kalogeropoulos; Arshed Quyyumi; Wendy Book Journal: Int J Cardiol Date: 2020-01-09 Impact factor: 4.164
Authors: Peter Jirak; Rudin Pistulli; Michael Lichtenauer; Bernhard Wernly; Vera Paar; Lukas J Motloch; Richard Rezar; Christian Jung; Uta C Hoppe; P Christian Schulze; Daniel Kretzschmar; Rüdiger C Braun-Dullaeus; Tarek Bekfani Journal: J Clin Med Date: 2020-04-15 Impact factor: 4.241
Authors: Marta Michalska-Kasiczak; Agata Bielecka-Dabrowa; Stephan von Haehling; Stefan D Anker; Jacek Rysz; Maciej Banach Journal: Arch Med Sci Date: 2018-06-11 Impact factor: 3.318